Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting [0.03%]
针对低HDL胆固醇以降低医疗保障体系中的残余心血管疾病风险
Mark J Cziraky,Karol E Watson,Robert L Talbert
Mark J Cziraky
Background: Most clinicians recognize the importance of reducing low-density lipoprotein cholesterol (LDL-C) and, therefore, address this therapeutic need to decrease cardiovascular disease risk. In addition to the critic...
Current and future directions in MS management: key considerations for managed care pharmacists [0.03%]
多发性硬化管理的现状与未来展望：Managed Care 药师须知要点
Robert J Lipsy,Randall T Schapiro,Chris R Prostko
Robert J Lipsy
Background: The management paradigm for multiple sclerosis (MS) continues to evolve and is shifting toward earlier diagnosis, differentiation of patients with varying clinical prognoses, and earlier initiation of treatmen...
Call for comparative effectiveness research: lowering A1c with sitagliptin, saxagliptin, or cinnamon [0.03%]
行动起来进行比较效果研究：西他列汀、沙格列汀或肉桂降低血糖指标A1c的作用研究
Kathleen A Fairman,Frederic R Curtiss
Kathleen A Fairman
J Daniel Allen,Frederic R Curtiss,Kathleen A Fairman
J Daniel Allen
Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals [0.03%]
成果付费：药品的创新型支付和报销方案
Josh J Carlson,Louis P Garrison Jr,Sean D Sullivan
Josh J Carlson
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer [0.03%]
晚期非小细胞肺癌一线化疗患者的中性粒细胞减少相关费用研究
Michael E Stokes,Catherine E Muehlenbein,Martin D Marciniak et al.
Michael E Stokes et al.
Background: Neutropenia is a major adverse event often associated with chemotherapy administration. Neutropenia-related complications often lead to increased use of costly health care including inpatient and outpatient se...
Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans [0.03%]
基于行政理赔资料的肺癌新发病例检出能力的队列研究：三种不同医疗计划的对比
Scott D Ramsey,John F Scoggins,David K Blough et al.
Scott D Ramsey et al.
Background: Administrative claims are readily available, but their usefulness for identifying persons with non-small cell lung cancer (NSCLC) is relatively unknown, particularly for younger persons and those enrolled in M...
Association of prescription abandonment with cost share for high-cost specialty pharmacy medications [0.03%]
患者药房自付费用对高成本特药处方放弃行为的影响关系分析
Patrick P Gleason,Catherine I Starner,Brent W Gunderson et al.
Patrick P Gleason et al.
Background: In 2008, specialty medications accounted for 15.1% of total pharmacy benefit medication spending, and per member expenditures have increased by 11.1% annually from 2004 to 2008 within a commercially insured po...